HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic anti-glioma effect of Hydroxygenkwanin and Apigenin in vitro.

Abstract
Apigenin (AP) and Hydroxygenkwanin (HGK) are two natural flavonoid compounds. Previous studies have already demonstrated the anti-tumor capability of AP. However, it is not clear whether HGK has such property. In the current study, the anti-glioma activities of HGK and its synergistic anti-glioma effects with AP on C6 glioma cells were investigated. In addition, the possible mechanisms were also studied. MTT assay and morphologic analysis including acridine orange/ethidium bromide (AO/EB) and 4',6-diamidino-2-phenylindole (DAPI) staining were used in the research, and the results indicated that the treatment with AP or HGK could inhibit C6 glioma cell proliferation respectively. Moreover, when AP was administrated simultaneously, the anti-glioma effect of HGK was dramatically enhanced in a dose-dependent manner, which is obviously better than that of carmustine (BCNU) at the concentration 25μM for treating of 24h. Compared with control, mitochondrial membrane potential (MPP) loss and mitochondrion damage were detected by JC-1 fluorescence probes (JC-1) and transmission electron microscopy (TEM) after treatment. Obvious DNA damage and cell cycle S phase arrest were detected by alkaline comet assay and flow cytometric analysis (FCM). Additionally, up regulation of TNF-α level, activations of caspase-3, -8, over expressions of BID and BAK protein and BCL-XL protein down expression were also observed after treatment by the combination of AP and HGK. The results indicate that HGK may be an effective natural product to treat glioma, and the combination of AP and HGK may be a promising method for glioma chemotherapy.
AuthorsYi Wang, You Song Xu, Lian Hong Yin, Li Na Xu, Jin Yong Peng, Hang Zhou, Wei Kang
JournalChemico-biological interactions (Chem Biol Interact) Vol. 206 Issue 2 Pg. 346-55 (Nov 25 2013) ISSN: 1872-7786 [Electronic] Ireland
PMID24144774 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • BH3 Interacting Domain Death Agonist Protein
  • Flavonoids
  • Fluorescent Dyes
  • Tumor Necrosis Factor-alpha
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-X Protein
  • hydroxygenkwanin
  • Apigenin
  • Caspase 3
  • Caspase 8
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (chemistry, pharmacology, therapeutic use)
  • Apigenin (chemistry, pharmacology, therapeutic use)
  • BH3 Interacting Domain Death Agonist Protein (metabolism)
  • Caspase 3 (metabolism)
  • Caspase 8 (metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • DNA Damage (drug effects)
  • Flavonoids (chemistry, pharmacology, therapeutic use)
  • Fluorescent Dyes (chemistry)
  • Glioma (drug therapy, metabolism, pathology)
  • Membrane Potential, Mitochondrial (drug effects)
  • Mitochondria (drug effects, metabolism)
  • PC12 Cells
  • Rats
  • S Phase Cell Cycle Checkpoints (drug effects)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Up-Regulation (drug effects)
  • bcl-2 Homologous Antagonist-Killer Protein (metabolism)
  • bcl-X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: